MA33602B1 - Composition pharmaceutique permettant de prévenir ou de traiter l'arthrite rhumatoïde, contenant du rébamipide - Google Patents
Composition pharmaceutique permettant de prévenir ou de traiter l'arthrite rhumatoïde, contenant du rébamipideInfo
- Publication number
- MA33602B1 MA33602B1 MA34713A MA34713A MA33602B1 MA 33602 B1 MA33602 B1 MA 33602B1 MA 34713 A MA34713 A MA 34713A MA 34713 A MA34713 A MA 34713A MA 33602 B1 MA33602 B1 MA 33602B1
- Authority
- MA
- Morocco
- Prior art keywords
- pharmaceutical composition
- rheumatoid arthritis
- ribamipid
- treatment
- arthritis containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Quinoline Compounds (AREA)
Abstract
La présente invention a pour objet une composition pharmaceutique permettant de prévenir ou de traiter l'arthrite rhumatoïde, contenant du rébamipide et un support pharmaceutiquement acceptable. La composition pharmaceutique peut se présenter sous la forme d'une administration orale, et de préférence encore, la composition pharmaceutique peut avoir une forme posologique orale solide d'un comprimé ou d'une capsule. En outre, la composition pharmaceutique peut être formulée dans une forme posologique unitaire appropriée à une administration orale avec une posologie du rébamipide de 0,5 à 50 mg/kg, et de préférence encore de 0,6 à 6 mg/kg.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090078547A KR101104634B1 (ko) | 2009-08-25 | 2009-08-25 | 레바미피드를 포함하는 류마티스 관절염 예방 또는 치료용 약학 조성물 |
PCT/KR2009/005753 WO2011025086A1 (fr) | 2009-08-25 | 2009-10-08 | Composition pharmaceutique permettant de prévenir ou de traiter larthrite rhumatoïde, contenant du rébamipide |
Publications (1)
Publication Number | Publication Date |
---|---|
MA33602B1 true MA33602B1 (fr) | 2012-09-01 |
Family
ID=43628165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA34713A MA33602B1 (fr) | 2009-08-25 | 2012-03-22 | Composition pharmaceutique permettant de prévenir ou de traiter l'arthrite rhumatoïde, contenant du rébamipide |
Country Status (10)
Country | Link |
---|---|
US (1) | US8691842B2 (fr) |
EP (1) | EP2471535B1 (fr) |
JP (1) | JP2013503153A (fr) |
KR (1) | KR101104634B1 (fr) |
CN (1) | CN102481298A (fr) |
BR (1) | BR112012003617A2 (fr) |
CA (1) | CA2770778C (fr) |
MA (1) | MA33602B1 (fr) |
RU (1) | RU2496497C1 (fr) |
WO (1) | WO2011025086A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101182114B1 (ko) * | 2010-03-05 | 2012-09-12 | 한림제약(주) | 유효성분으로서 레바미피드를 함유하는 골관절염 예방 또는 치료용 약학 조성물 |
KR101317507B1 (ko) * | 2010-08-30 | 2013-10-15 | 가톨릭대학교 산학협력단 | 레바미피드를 유효성분으로 포함하는 암 또는 면역질환의 예방 또는 치료용 조성물 |
JP5707137B2 (ja) * | 2011-01-06 | 2015-04-22 | 学校法人東京女子医科大学 | レバミピドの骨粗鬆症治療用途 |
KR101395984B1 (ko) * | 2011-10-21 | 2014-05-16 | 가톨릭대학교 산학협력단 | 레바미피드를 유효성분으로 포함하는 비만의 예방 또는 치료용 조성물 |
KR101436728B1 (ko) | 2012-03-20 | 2014-09-02 | 가톨릭대학교 산학협력단 | 골수유래억제세포 및 레바미피드를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물 |
CN109381466A (zh) * | 2017-08-02 | 2019-02-26 | 中国药科大学 | 促进糖尿病病人伤口愈合的治疗剂 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1740003A1 (ru) * | 1989-05-24 | 1992-06-15 | Киевский Медицинский Институт Им.Акад.А.А.Богомольца | Способ лечени ревматоидного артрита |
RU1816457C (ru) * | 1990-12-13 | 1993-05-23 | Московский медицинский стоматологический институт им.Н.А.Семашко | Способ лечени ревматоидного артрита |
CN1073418C (zh) * | 1993-10-21 | 2001-10-24 | 大塚制药株式会社 | 白细胞介素-8生成抑制剂 |
EP1336602A1 (fr) * | 2002-02-13 | 2003-08-20 | Giovanni Scaramuzzino | Prodrogues nitrées capable de libérer du monoxyde d'azote de manière controlée et sélective ainsi que leur utilisation pour la prévention et le traitement de maladies inflammatoires, ischémiques et proliferatives |
JP2004155781A (ja) * | 2002-10-17 | 2004-06-03 | Tokuyuki Namiki | 口腔内速崩錠 |
-
2009
- 2009-08-25 KR KR1020090078547A patent/KR101104634B1/ko active IP Right Grant
- 2009-10-08 CA CA2770778A patent/CA2770778C/fr not_active Expired - Fee Related
- 2009-10-08 CN CN2009801610990A patent/CN102481298A/zh active Pending
- 2009-10-08 BR BR112012003617A patent/BR112012003617A2/pt not_active IP Right Cessation
- 2009-10-08 WO PCT/KR2009/005753 patent/WO2011025086A1/fr active Application Filing
- 2009-10-08 RU RU2012106168/15A patent/RU2496497C1/ru not_active IP Right Cessation
- 2009-10-08 EP EP09848789.5A patent/EP2471535B1/fr not_active Not-in-force
- 2009-10-08 JP JP2012526612A patent/JP2013503153A/ja active Pending
- 2009-10-08 US US13/392,197 patent/US8691842B2/en not_active Expired - Fee Related
-
2012
- 2012-03-22 MA MA34713A patent/MA33602B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
JP2013503153A (ja) | 2013-01-31 |
BR112012003617A2 (pt) | 2016-02-23 |
EP2471535B1 (fr) | 2018-05-23 |
CA2770778A1 (fr) | 2011-03-03 |
KR20110021016A (ko) | 2011-03-04 |
CA2770778C (fr) | 2016-06-14 |
US8691842B2 (en) | 2014-04-08 |
KR101104634B1 (ko) | 2012-01-12 |
EP2471535A4 (fr) | 2013-03-06 |
RU2496497C1 (ru) | 2013-10-27 |
CN102481298A (zh) | 2012-05-30 |
WO2011025086A1 (fr) | 2011-03-03 |
EP2471535A1 (fr) | 2012-07-04 |
US20120172394A1 (en) | 2012-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA33602B1 (fr) | Composition pharmaceutique permettant de prévenir ou de traiter l'arthrite rhumatoïde, contenant du rébamipide | |
MA30807B1 (fr) | Compositions pharmaceutiques. | |
MA32692B1 (fr) | Procede de liberation d'une composition pharmaceutique a un patient qui en a besoin | |
MA34296B1 (fr) | Composition retard injectable antipsychotique | |
MA33056B1 (fr) | Composition pharmaceutique solide comprenant de l'amlodipine et du losartan et son procede de fabrication | |
MA38146B1 (fr) | Nouveaux dérivés du benzimidazole comme antagonistes ep4 | |
MA35753B1 (fr) | Aryl-dihydropyridinones et pipéridinones en tant qu'inhibiteurs de mgat2 | |
NZ599847A (en) | Pharmaceutical composition comprising a glp-1 agonist and methionine | |
NZ596879A (en) | Tamper resistant dosage form comprising a matrix and melt - extruded particulates comprising a drug | |
EA201071054A1 (ru) | Твердый препарат, растворяющийся во рту | |
MA33295B1 (fr) | Nouvelle formulation de diclofénac | |
GEP20156281B (en) | Orally administered corticosteroid compositions | |
EP2248519A3 (fr) | Formes galéniques de film non mucoadhésifs | |
TW200744677A (en) | Compositions and methods for preparation of poorly water soluble drugs with increased stability | |
MX346335B (es) | Composiciones antisentido, y metodos para obtener y usar las mismas. | |
TNSN08428A1 (fr) | NOUVELLE FORME d'ADMINISTRATION DU RACECADOTRIL | |
MA44206A (fr) | Comprimé orodispersible comprenant estetrol | |
MX2010007083A (es) | Combinacion anti-retroviral. | |
MA29722B1 (fr) | Schema posologique pour le prasugrel | |
MA33463B1 (fr) | Compositions à dose pharmaceutique solide fixe comprenant de l'irbésartan et de l'amlodipine, leur préparation et leur application thérapeutique | |
MA34313B1 (fr) | Formulation pharmaceutique sous la forme de comprimés bicouches comprenant un inhibiteur de hmg-coa réductase et d'irbésartan | |
MY139086A (en) | Use of debranched starch in extrusion-spheronization pharmaceutical pellets | |
MA31706B1 (fr) | Formulations galéniques de composés organiques | |
TR200101719T2 (tr) | Erkeklerde organik ereksiyona bağlı işlev bozukluğunun tedavisi için ilaç imalatında apomorfin kullanımı | |
MX2019001596A (es) | Uso y dosificacion de agentes terapeuticos para endometriosis. |